about
Long non-coding RNAs in anti-cancer drug resistanceCancer stem cells as a potential therapeutic target in thyroid carcinoma.Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.Targeted Therapy for Medullary Thyroid Cancer: A Review.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
New drugs for medullary thyroid cancer: new promises?
@ast
New drugs for medullary thyroid cancer: new promises?
@en
New drugs for medullary thyroid cancer: new promises?
@nl
type
label
New drugs for medullary thyroid cancer: new promises?
@ast
New drugs for medullary thyroid cancer: new promises?
@en
New drugs for medullary thyroid cancer: new promises?
@nl
prefLabel
New drugs for medullary thyroid cancer: new promises?
@ast
New drugs for medullary thyroid cancer: new promises?
@en
New drugs for medullary thyroid cancer: new promises?
@nl
P2093
P356
P1476
New drugs for medullary thyroid cancer: new promises?
@en
P2093
Christine Spitzweg
John C Morris
Keith C Bible
P304
P356
10.1530/ERC-16-0104
P407
P577
2016-06-01T00:00:00Z